Gentamicin susceptibility in Escherichia coli related to the genetic background: problems with breakpoints

Clin Microbiol Infect. 2007 Aug;13(8):830-2. doi: 10.1111/j.1469-0691.2007.01751.x. Epub 2007 May 14.

Abstract

In total, 120 Escherichia coli isolates positive for one of the gentamicin resistance (GEN(R)) genes aac(3)-II, aac(3)-IV or ant(2'')-I were tested for gentamicin susceptibility by the agar dilution method. Isolates positive for aac(3)-IV or ant(2'')-I had an MIC distribution of 8-64 mg/L, whereas isolates positive for aac(3)-II had MICs of 32 to >512 mg/L, suggesting a relationship between the distribution of MICs and the specific GEN(R) mechanism. The MIC distribution, regardless of the GEN(R) mechanism, was 8 - >512 mg/L, which supports the clinical breakpoint of MIC >4 mg/L suggested by EUCAST and questions the breakpoint recommended by the CLSI (> or =16 mg/L).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetyltransferases / genetics
  • Anti-Bacterial Agents / pharmacology*
  • Drug Resistance, Bacterial / genetics*
  • Escherichia coli* / drug effects
  • Escherichia coli* / genetics
  • Gentamicins / pharmacology*
  • Humans
  • Microbial Sensitivity Tests / methods

Substances

  • Anti-Bacterial Agents
  • Gentamicins
  • Acetyltransferases
  • aminoglycoside N(3')-acetyltransferase